Document Type : Original Article


1 Department of Food Hygiene and Quality Control, Epidemiology & Zoonoses Division of Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran

2 Department of Epidemiology, School of Public Health, Mashhad University of Medical Sciences, Mashhad, Iran


Background and aims: Urinary tract infections (UTIs) are intense public health problems and are precipitated by a variety of pathogens. This study was performed to determine the frequency of bacterial agents of UTIs and the antibiotic resistance pattern of Escherichia coli in urinary culture samples of patients at Shahid Ashrafi Esfahani hospital in Tehran, Iran.
Methods: A cross-sectional study was conducted on all urinary tract cultures from January 2021 to January 2022 at Shahid Ashrafi Esfahani hospital in Tehran, Iran. Urine culture and antimicrobial susceptibility tests were performed according to Clinical and Laboratory Standards Institute (CLSI) guidelines. Statistical analyses were performed by appropriate descriptive and inferential tests such as the chi-square test using Stata version 17, and the level of significance was set at 0.05.
Results: The mean age of patients with E. coli was 50.2 ± 1.8 (confidence interval = 46.6-53.8) years, and their age range was between 6-87 years. The highest prevalence of infection occurred in men over 60 years of age and in women aged 40-60 years. Further, the highest resistance and the highest sensitivity were related to ceftazidime (CAZ) and cefotaxime (CTX), respectively.
Conclusion: In this study, the highest resistance and sensitivity belonged to CAZ and CTX, respectively. In addition, CTX is the primary antibiotic prescribed to deal with UTIs in medical practice.


1. Jeśman C, Młudzik A, Cybulska M. [History of antibiotics and sulphonamides discoveries]. Pol Merkur Lekarski. 2011;30(179):320-2. 
2. Kourkouta L, Koukourikos K, Iliadis C, Plati P, Dimitriadou A. History of antibiotics. Sumer J Med Healthc. 2018;1(2):51-4. 
3. Hooper DC. Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis. 2001;7(2):337-41. doi: 10.3201/ eid0702.010239. 
4. Hernando-Amado S, Coque TM, Baquero F, Martínez JL. Defining and combating antibiotic resistance from One Health and Global Health perspectives. Nat Microbiol. 2019;4(9):1432-42. doi: 10.1038/s41564-019-0503-9. 
5. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-81. doi: 10.1111/j.1469-0691.2011.03570.x. 
6. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269-84. doi: 10.1038/nrmicro3432. 
7. World Health Organization (WHO). Antimicrobial Resistance Surveillance in Europe 2022-2020 Data. WHO; 2022. 
8. van Driel AA, Notermans DW, Meima A, Mulder M, Donker GA, Stobberingh EE, et al. Antibiotic resistance of Escherichia coli isolated from uncomplicated UTI in general practice patients over a 10-year period. Eur J Clin Microbiol Infect Dis. 2019;38(11):2151-8. doi: 10.1007/s10096-019-03655-3. 
9. Terlizzi ME, Gribaudo G, Maffei ME. UroPathogenic Escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. Front Microbiol. 2017;8:1566. doi: 10.3389/ fmicb.2017.01566. 
10. Azami M, Jaafari Z, Masoumi M, Shohani M, Badfar G, Mahmudi L, et al. The etiology and prevalence of urinary tract infection and asymptomatic bacteriuria in pregnant women in Iran: a systematic review and meta-analysis. BMC Urol. 2019;19(1):43. doi: 10.1186/s12894-019-0454-8. 
11. Hedayat Yaghoobi M, Karami P, Khaledi A, Rafie E, Sabahi M, Habibipour B, et al. Comparison of antimicrobial resistance pattern in hospital versus community-acquired infections in pediatric patients. J Adv Med Biomed Res. 2019;27(123):1-8. doi: 10.30699/jambs.27.123.1. 
12. Karimian M, Kermani R, Khaleghi M, Kelishadi R, Ataei B, Mostafavi N. Antibiotic susceptibility patterns of isolates from children with urinary tract infection in Isfahan, Iran: impact on empirical treatment. J Glob Antimicrob Resist. 2017;9:3-7. doi: 10.1016/j.jgar.2016.12.014. 
13. Vélez Echeverri C, Serna-Higuita LM, Serrano AK, Ochoa- García C, Rojas Rosas L, María Bedoya A, et al. Resistance profile for pathogens causing urinary tract infection in a pediatric population, and antibiotic treatment response at a university hospital, 2010-2011. Colomb Med (Cali). 2014;45(1):39-44. 
14. Barari Sawadkouhi R, Sorkhi H, Pournasrollah M. Antibiotic resistance of bacteria causing urinary tract infections in hospitalized patients in the pediatric subspecialty hospital of Amir Kala, Babol, 2002-2005. Iran J Infect Dis Trop Med. 2008;39:25-8. 
15. Vaezzadeh F, Sharifi-Yazdi MK. Laboratory evaluation of urine culture and drug resistance in childern clinically suspected of urinary tract infection (UTI). Iran J Public Health. 2001;30(3- 4):123-4. 
16. Padda IS, Nagalli S. Cefotaxime. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2021. 
17. Oteo J, Navarro C, Cercenado E, Delgado-Iribarren A, Wilhelmi I, Orden B, et al. Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. J Clin Microbiol. 2006;44(7):2359-66. doi: 10.1128/jcm.00447-06. 
18. Ayatollahi J, Shahcheraghi SH, Akhondi R, Soluti S. Antibiotic resistance patterns of Escherichia coli isolated from children in Shahid Sadoughi hospital of Yazd. Iran J Ped Hematol Oncol. 2013;3(2):78-82. 
19. Mohanty S, Kapil A, Das BK, Dhawan B. Antimicrobial resistance profile of nosocomial uropathogens in a tertiary care hospital. Indian J Med Sci. 2003;57(4):148-54. 
20. Butta H, Kaistha N, Gupta V, Chander J. Choice of antibiotics in community acquired UTI due to Escherichia coli in adult age group. J Clin Diagn Res. 2011;5(3):483-5.